The following is a summary of the Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript:

Financial Performance:

• Q2 2024 revenue was $34.4 million, down from $61.8 million in Q2 2023, a 44% decrease year-over-year.

• Non-GAAP gross profit for Q2 2024 was $9.6 million, with a gross margin rate of 28.8%.

• Non-GAAP loss from operations for Q2 2024 was $21.3 million.

• Cutera provided revised full-year revenue guidance to $140 million to $145 million from a prior range of $160 million to $170 million.

Business Progress:

• International launch of AviClear was successful, with over 70 systems sold outside of North America.

• New capital sales organization structure implemented in North America.

• Partnership established with L'Oreal's SkinCeuticals business in Japan, expected to launch in Q4 2024.

Opportunities:

• The international success of AviClear and restructuring in North America present opportunities for growth and improved sales productivity.

• The new partnership with L'Oreal's SkinCeuticals in Japan represents potential growth in skincare.

Risks:

• Continued macroeconomic pressures affecting capital equipment revenue, particularly in North America.

• High sales force turnover in North America impacting short-term revenue.

More details: Cutera IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.